Efficacy News and Research

RSS
Expert discusses certain measures that can help prevent HAI spread

Expert discusses certain measures that can help prevent HAI spread

Naltrexone may be effective in women with specific genetic variation

Naltrexone may be effective in women with specific genetic variation

The Lancet Neurology publishes Neurologix NLX-P101 Phase 2 trial results against PD

The Lancet Neurology publishes Neurologix NLX-P101 Phase 2 trial results against PD

NAFC honors Florida's Cleveland Clinic physician with Continence Care Champion Award

NAFC honors Florida's Cleveland Clinic physician with Continence Care Champion Award

Montreal Heart Institute and Cerenis commence CER-001 Phase 2 study in acute coronary syndrome

Montreal Heart Institute and Cerenis commence CER-001 Phase 2 study in acute coronary syndrome

AstraZeneca commences NKTR-118 Phase III clinical programme for opioid-induced constipation

AstraZeneca commences NKTR-118 Phase III clinical programme for opioid-induced constipation

Gadavist approved by FDA for use in central nervous system MRI scans

Gadavist approved by FDA for use in central nervous system MRI scans

Enzo Life Sciences introduces ELISA system to detect SMN protein

Enzo Life Sciences introduces ELISA system to detect SMN protein

Argon acquires global rights to market, distribute Rex Medical's Option Retrievable Inferior Vena Cava Filter

Argon acquires global rights to market, distribute Rex Medical's Option Retrievable Inferior Vena Cava Filter

XTIO2 presents XTI 360 ANTI-GERM SYSTEM to 83rd Academy Award-nominees

XTIO2 presents XTI 360 ANTI-GERM SYSTEM to 83rd Academy Award-nominees

Type 2 diabetes drug less likely to cause weight gain, raise cholesterol levels

Type 2 diabetes drug less likely to cause weight gain, raise cholesterol levels

Oxford Biomedica’s TroVax(R) TRIST Phase III study results to be published in Cancer Immunology, Immunotherapy

Oxford Biomedica’s TroVax(R) TRIST Phase III study results to be published in Cancer Immunology, Immunotherapy

Cerenis commences CER-001 Phase 2 CHI-SQUARE study in patients with ACS

Cerenis commences CER-001 Phase 2 CHI-SQUARE study in patients with ACS

ExonHit receives CE mark approval for AclarusDx to diagnose AD

ExonHit receives CE mark approval for AclarusDx to diagnose AD

Covidien to present new data on hernia, abdominal wall repair products at San Francisco

Covidien to present new data on hernia, abdominal wall repair products at San Francisco

New study: Two peptide agent combination might block tumor growth

New study: Two peptide agent combination might block tumor growth

Positive top-line results from IPX066 Phase III study in patients with PD

Positive top-line results from IPX066 Phase III study in patients with PD

Repligen reports positive results from RG1068 Phase 3 study to improve MRI of the pancreas

Repligen reports positive results from RG1068 Phase 3 study to improve MRI of the pancreas

Euthymics Bioscience initiates EB-1010 phase 2b/3a TRIADE clinical trial for major depressive disorder

Euthymics Bioscience initiates EB-1010 phase 2b/3a TRIADE clinical trial for major depressive disorder

Biodel selects BIOD-105, BIOD-107 recombinant human insulin formulations for clinical testing, development

Biodel selects BIOD-105, BIOD-107 recombinant human insulin formulations for clinical testing, development

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.